Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Breakthrough Genomics, |
RCV004596667 | SCV005088734 | likely pathogenic | Leber congenital amaurosis 10 | 2021-08-03 | criteria provided, single submitter | clinical testing | This variant lies in the essential splice donor site, in intron 39 of the CEP290 gene. In silico splice prediction tools (ASSP and NNSPLICE) suggest that this variant might affect splicing due to the loss of constitutive splice site and introduction of a new splice site, which in turn might lead to a frameshift and consequent premature termination of the protein; this will likely result in loss-of-function. The variant seems to be a novel variant, as it has not been previously reported in population or public databases or in the literature. However, splice variants, lying downstream of the variant, have been reported as pathogenic/likely pathogenic in the ClinVar database in the context of Leber congenital amaurosis. Loss-of-function variants in the CEP290 gene are known as pathogenic [PMID: 16909394, 17345604, 20690115, 25377065, 28559085]. |
| Fulgent Genetics, |
RCV005006455 | SCV005629997 | likely pathogenic | Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14 | 2024-04-19 | criteria provided, single submitter | clinical testing |